Finance

Lists
Why is VTGN down १०.३६%?
Dive Deeper
VTGN:NASDAQ
Vistagen Therapeutics Inc
US$ ०.१७
-१०.३६%
(-०.०१९) 1D
US$ ०.१७
+१.९४% (+०.००३२)
After hours
Closed: नोभेम्बर ५, १६:००:०१ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTGN...
Open
US$ ०.१८
High
US$ ०.१८
Low
US$ ०.१७
Mkt. cap
७५.०६ लाख
Avg. vol.
१९.९७ लाख
Volume
१०.३४ लाख
52-wk high
US$ ५.१४
52-wk low
US$ ०.१७
EPS
-US$ १.६८
Beta
०.४९
Shares outstanding
४.४४ करोड
No. of employees
४१
Open
US$ ०.१८
High
US$ ०.१८
Low
US$ ०.१७
Mkt. cap
७५.०६ लाख
Avg. vol.
१९.९७ लाख
Volume
१०.३४ लाख
52-wk high
US$ ५.१४
52-wk low
US$ ०.१७
EPS
-US$ १.६८
Beta
०.४९
Shares outstanding
४.४४ करोड
No. of employees
४१
News stories
From web sources and news partners
CNBC
CNBC
·
३४ मिनेट पहिले
Nasdaq drops into correction territory — here’s what typically happens next
Quantisnow
Quantisnow
·
६ मिनेट पहिले
Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases
TradingView
TradingView
·
३७ मिनेट पहिले
Blink Charging (NASDAQ:BLNK) misses Q3 2026 sales expectations
Fox Business
Fox Business
·
१ घण्टा पहिले
Stocks plunge as Dem midterm sweep fuels AI regulatory concerns
About Vistagen Therapeutics Inc
CEO-
Employees४१
Founded१९९८
HeadquartersSouth San Francisco, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websitevistagen.com
Analyst ratings
Based on 1 analyst giving stock ratings to VTGN in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for VTGN in the last 3 months
Highest
Current US$ ०.१७
(-१००.००%)
Average
(-१००.००%)
Lowest
(-१००.००%)
Analyst
Recommendation
Action
Price target
Projected
Date
Myles Minter
William Blair
Hold
Maintained
-
-
09/23/2026
Paul Matteis
Stifel Nicolaus
Hold
Maintained
US$ १.००
+५०५.३%
07/06/2026
Andrew Tsai
Jefferies
Hold
Downgraded
US$ ०.९०
+४४४.८%
12/17/2025
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
२.५८ लाख
३.०३ लाख
४.६५ लाख
१४.७६ लाख
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
१.५९ करोड
१.४२ करोड
१.३१ करोड
१.०९ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४३.९६ लाख
५६.२६ लाख
४१.२२ लाख
३९.१८ लाख
Operating expense
२.०३ करोड
१.९८ करोड
१.७२ करोड
१.४८ करोड
Total operating expenses
२.०३ करोड
१.९८ करोड
१.७२ करोड
१.४८ करोड
Operating income
-२.०१ करोड
-१.९५ करोड
-१.६७ करोड
-१.३३ करोड
Other non operating income
६.०० हजार
-
-२.०० हजार
-१.०० हजार
EBT including unusual items
-१.९४ करोड
-१.८९ करोड
-१.६३ करोड
-१.३० करोड
EBT excluding unusual items
-१.९४ करोड
-१.८९ करोड
-१.६३ करोड
-१.३० करोड
Income tax expense
-
-
७.०० हजार
-
Effective tax rate
-
-
-०.०४%
-
Other operating expenses
-
-
-
-
Net income
-१.९४ करोड
-१.८९ करोड
-१.६३ करोड
-१.३० करोड
Net profit margin
-७,५२५.९७%
-६,२३७.२९%
-३,४९९.७८%
-८८२.७९%
Earnings per share
-०.५४
-०.४५
-०.३७
-०.३०
Interest and investment income
६.३० लाख
६.४७ लाख
४.५२ लाख
३.१९ लाख
Interest expense
-
-
-
-
Net interest expenses
६.३० लाख
६.४७ लाख
४.५२ लाख
३.१९ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.०० करोड
-१.९५ करोड
-१.६७ करोड
-१.३३ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google एपहरू